Asure Software, Inc. (ASUR)

NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-10-23

$7.36+0.14%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Asure Software, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

0.0%

+10% or more+5%0%−5%−10% or less

1.08 → 1.08 EPS · FY ending Dec 31, 2027 · 5 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$38M–$40M	—
EBITDA	$8M–$10Mnon-GAAP	—
FY 2026 · Q4
Revenue	—	41.76M
EPS	—	0.24
FY 2026 · Annual
Revenue	$159M–$163M	160.57M
EPS	—	0.861
FY 2027 · Annual
Revenue	—	174.45M
EPS	—	1.078

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Improve operating income above $2.3M in Q1 2026	Operating income improved to $2.33M in Q1.	Under Pressure	Operating income falls below $2.3M in Q1 2026	Operating income: $-2.396M FY2026-Q2; GAAP. Published target: >= $2.33M. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Jul 30, 2026-2,396,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: dc108bb6-e247-4748-81af-61a177ebd527. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Operating income improved significantly from a loss of $3.499 million in 2025-Q3 to a positive $2.329 million in 2026-Q1. EBITDA also increased from $4.1 million in 2025-Q1 to $9.4 million in 2026-Q1. These trends show management is delivering on improving operating income. Delivery assessment Oct 24, 2026
Achieve Q2 2026 revenue of $36M-$38M	A supporting condition in Asure Software, Inc.'s published investment case. The stated target is ~$37M.	Intact	Q2 revenue falls below $36M	Revenue: $37.113M FY2026-Q2; GAAP. Published target: ~$37M. The target does not explicitly identify fiscal versus calendar quarters. Source published Jul 30, 202637,113,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: dc108bb6-e247-4748-81af-61a177ebd527. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Management consistently guided Q2 2026 revenue between $36.0 million and $38.0 million. Actual Q2 2026 revenue was $37.1 million, a 23% increase from $30.1 million in Q2 2025, demonstrating delivery on this quarterly growth target. Delivery assessment Oct 24, 2026
Achieve revenue of $159M-$163M in fiscal 2026	A primary condition in Asure Software, Inc.'s published investment case. The stated target is ~$161M.	Intact	Revenue falls below $159M in FY26	Revenue: $37.113M FY2026-Q2; GAAP. Published target: ~$161M. Target period is not explicitly aligned with this observation. Source published Jul 30, 202637,113,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: dc108bb6-e247-4748-81af-61a177ebd527. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Management guided full-year 2026 revenue between $159.0 million and $163.0 million consistently from 2025-Q3 through 2026-Q2. First half 2026 revenue was $79.9 million, up 23% year over year, indicating the company is delivering on its growth trajectory toward the full-year target. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.08

$1.06 → $1.08 · observed estimates

FY2027 revenue$0.17B

$0.17B → $0.17B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.06	$174,625,140	5 / 7
2026-07-25	$1.06	$174,625,140	5 / 7
2026-07-26	$1.06	$174,625,140	5 / 7
2026-07-27	Unavailable	$174,668,000	4 / 5
2026-07-28	$1.06	$174,625,140	5 / 7
2026-07-29	$1.06	$174,625,140	5 / 7
2026-07-30	$1.06	$174,625,140	5 / 7
2026-07-31	$1.06	$174,625,140	5 / 7
2026-08-01	$1.06	$174,625,140	5 / 7
2026-08-02	$1.08	$174,691,290	5 / 7
2026-08-03	$1.08	$174,691,290	5 / 7
2026-08-04	$1.08	$174,691,290	5 / 7
2026-08-05	$1.08	$174,734,140	5 / 7
2026-08-06	$1.08	$174,734,140	5 / 7
2026-08-07	Unavailable	$174,734,143	3 / 5
2026-08-08	$1.08	$174,548,430	5 / 7
2026-08-09	$1.08	$174,548,430	5 / 7
2026-08-10	$1.08	$174,548,430	5 / 7
2026-08-11	$1.08	$174,548,430	5 / 7
2026-08-12	$1.08	$174,548,430	5 / 7
2026-08-13	$1.08	$174,548,430	5 / 7
2026-08-14	Unavailable	$174,734,143	3 / 5
2026-08-15	Unavailable	$174,734,143	3 / 5
2026-08-16	Unavailable	$174,734,143	3 / 5
2026-08-17	Unavailable	$174,734,143	3 / 5
2026-08-18	Unavailable	$174,734,143	3 / 5
2026-08-19	Unavailable	$174,734,143	3 / 5
2026-08-20	Unavailable	$174,548,429	4 / 5
2026-08-21	Unavailable	$174,548,429	4 / 5
2026-08-22	Unavailable	$174,548,429	4 / 5
2026-08-23	Unavailable	$174,548,429	4 / 5
2026-08-24	Unavailable	$174,548,429	4 / 5
2026-08-25	Unavailable	$174,548,429	4 / 5
2026-08-26	Unavailable	$174,548,429	4 / 5
2026-08-27	Unavailable	$174,548,429	4 / 5
2026-08-28	Unavailable	$174,548,429	4 / 5
2026-08-29	Unavailable	$174,548,429	4 / 5
2026-08-30	Unavailable	$174,548,429	4 / 5
2026-08-31	Unavailable	$174,548,429	4 / 5
2026-09-01	Unavailable	$174,548,429	4 / 5
2026-09-02	Unavailable	$174,548,429	4 / 5
2026-09-03	Unavailable	$174,548,429	4 / 5
2026-09-04	Unavailable	$174,454,875	4 / 5
2026-09-05	$1.08	$174,454,875	5 / 6
2026-09-06	$1.08	$174,454,875	5 / 6
2026-09-07	$1.08	$174,454,875	5 / 6
2026-09-08	$1.08	$174,454,875	5 / 6
2026-09-09	$1.08	$174,454,875	5 / 6
2026-09-10	$1.08	$174,454,875	5 / 6
2026-09-11	$1.08	$174,454,875	5 / 6
2026-09-12	$1.08	$174,454,875	5 / 6
2026-09-13	$1.08	$174,454,875	5 / 6
2026-09-14	$1.08	$174,454,875	5 / 6
2026-09-15	$1.08	$174,454,875	5 / 6
2026-09-16	$1.08	$174,454,875	5 / 6
2026-09-17	$1.08	$174,454,875	5 / 6
2026-09-18	$1.08	$174,454,875	5 / 6
2026-09-19	$1.08	$174,454,875	5 / 6
2026-09-20	$1.08	$174,454,875	5 / 6
2026-09-21	$1.08	$174,454,875	5 / 6
2026-09-22	$1.08	$174,454,875	5 / 6
2026-09-23	$1.08	$174,454,875	5 / 6
2026-09-24	$1.08	$174,454,875	5 / 6
2026-09-25	$1.08	$174,454,875	5 / 6
2026-09-26	$1.08	$174,454,875	5 / 6
2026-09-27	$1.08	$174,454,875	5 / 6
2026-09-28	$1.08	$174,454,875	5 / 6
2026-09-29	$1.08	$174,454,875	5 / 6
2026-09-30	$1.08	$174,454,875	5 / 6
2026-10-01	$1.08	$174,454,875	5 / 6
2026-10-02	$1.08	$174,454,875	5 / 6
2026-10-03	$1.08	$174,454,875	5 / 6
2026-10-04	$1.08	$174,454,875	5 / 6
2026-10-05	$1.08	$174,454,875	5 / 6
2026-10-06	$1.08	$174,454,875	5 / 6
2026-10-07	$1.08	$174,454,875	5 / 6
2026-10-08	$1.08	$174,454,875	5 / 6
2026-10-09	$1.08	$174,454,875	5 / 6
2026-10-10	$1.08	$174,454,875	5 / 6
2026-10-11	$1.08	$174,454,875	5 / 6
2026-10-12	$1.08	$174,454,875	5 / 6
2026-10-13	$1.08	$174,454,875	5 / 6
2026-10-14	$1.08	$174,454,875	5 / 6
2026-10-15	$1.08	$174,454,875	5 / 6
2026-10-16	$1.08	$174,454,875	5 / 6
2026-10-17	$1.08	$174,454,875	5 / 6
2026-10-18	$1.08	$174,454,875	5 / 6
2026-10-19	$1.08	$174,454,875	5 / 6
2026-10-20	$1.08	$174,454,875	5 / 6
2026-10-21	$1.08	$174,454,875	5 / 6
2026-10-22	$1.08	$174,454,875	5 / 6
2026-10-23	$1.08	$174,454,875	5 / 6
2026-10-24	$1.08	$174,454,875	5 / 6

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	9	0	0
2026-06-01	9	0	0
2026-07-01	8	0	0
2026-08-01	8	0	0
2026-09-01	9	0	0
2026-10-01	9	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 9 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Improve operating income above $2.3M in Q1 2026Published status: Under Pressure
Achieve Q2 2026 revenue of $36M-$38MRevenue: $37.113M
Achieve revenue of $159M-$163M in fiscal 2026Revenue: $37.113M

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.4%Typical daily move · historical

Downside history

-31.6%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Asure Software, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

ASUR is a smaller-cap growth and execution story, not yet a proven durable compounder, because the evidence still classifies earnings quality as loss-making. The long-term thesis is improving: management has met recent revenue goals and operating results have strengthened, while the current thesis state remains watch.

What's priced into Asure Software, Inc.

The valuation evidence says ASUR is cheap versus peers, but the expectations gap is negative, which indicates market expectations remain a concern. The priced-in assessment is tagged justified, with low fragility; evidence does not support a more precise claim about what investors assume.

What the fundamentals likely do

Near-term, management is on track with its 2026 revenue goals: first-half revenue grew 23% year over year, and Q2 revenue reached the stated range. Operating results have improved, but the business is still classified as loss-making, and recent performance has lagged its industry cohort; the estimated miss risk is 37%, with smaller-company size and peer misses noted as concerns.

What Asure Software, Inc. hinges on

The multi-year thesis depends on sustaining revenue growth and further improving operating income. Near-term, a guidance cut would be a meaningful negative, while easier interest rates or continued strong results from sector bellwethers could support the broader technology backdrop. Recent filings include termination of a material agreement and unregistered equity sales, but the evidence does not explain their business impact.